The Pharmaceutical Market: China

News provided by

Jun 26, 2012, 08:02 ET

NEW YORK, June 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Pharmaceutical Market: China

http://www.reportlinker.com/p0203118/The-Pharmaceutical-Market-China.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series. A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

TABLE OF CONTENTS

Snapshot: Strategic Espicom Analysis 2

Snapshot: Key Data Projections3

MACROENVIRONMENT 4

POLITICAL 4

ECONOMIC 5

Projections 5

Government's Revaluation of CNY 6

LEGAL 6

Administrative Protection 7

USTR Status 7

DEMOGRAPHIC 8

Projections 8

Current Figures 9

Demographic Indicators 9

Births 9

Deaths 9

Infant Deaths 9

Life Expectancy at Birth 9

EPIDEMIOLOGY 10

DISEASE BURDEN 10

Leading Causes of Mortality 10

DISEASE PREVALENCE11

Communicable Diseases 11

HIV/AIDS 11

Non-communicable Diseases 12

Diabetes 12

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 13

ORGANISATION 13

Healthcare Reform Plan 13

Ministry of Health13

Hospitals 13

Rural Healthcare 14

Red Cross Society of China 14

EXPENDITURE 15

Projections 15

Latest Figures 16

Health Insurance 16

Public Health Insurance 16

Private Health Insurance 18

INFRASTRUCTURE 18

Hospital Infrastructure18

Outpatient Infrastructure 19

SERVICES 20

Inpatient Analysis20

Outpatient Analysis 21

WORKFORCE 22

Projections 22

Current State 23

REGULATORY AFFAIRS 24

NATIONAL AUTHORITY 24

Department of Drug Registration24

REGULATORY DEVELOPMENTS 24

SFDA Starts Overseas Factory Inspections 24

Revised GMP Regulations 25

Revised Antibiotic Regulations 25

MARKETING REGISTRATION 25

Department of Drug Safety & Inspection 26

Department of Drug Market Compliance 26

Drug Classification 27

Regulatory Legislation27

2001 DAL Amendments 27

Drug Import Regulation 28

GMP Regulations 28

Drug Approval Process 28

Clinical Trials28

Quality Tests29

Certification 29

PACKAGING 29

POST-MARKETING SURVEILLANCE 30

Revoked Licences30

Bribery Cases 30

PROMOTION 30

Advertising 30

PRICING & REIMBURSEMENT 31

PRICING 31

National Pricing31

REIMBURSEMENT 32

DISTRIBUTION CHANNELS 34

DRUG WHOLESALING 34

Selected Wholesalers35

Alliance Boots35

China Medical System 35

Chindex 35

First China Pharmaceutical Group 36

Global Pharm Holdings Group 37

Guangzhou Pharmaceutical 37

Hutchison China MediTech 38

Jointown Pharmaceutical Group 38

Nanjing Pharmaceutical 39

Shanghai Pharmaceuticals 39

Sinopharm40

DRUG RETAILING42

Selected Pharmacy Chains42

China BCT Pharmacy Group 42

ShenZhen Nepstar 42

MARKET ANALYSIS 43

SIZE 43

Projections 43

Historical Figures 45

Current Structure 46

PRODUCT DEVELOPMENT 48

12th Five-Year Plan 2011-2015 48

Mega New Drug Development Programme 48

SFDA R&D Initiatives 48

Beijing Economic-Technological Development Area49

Zhangjiang Hi-Tech Park 49

MANUFACTURING 50

China to Turn Five Companies into International Producers 52

TRADE52

Exports 52

Imports 55

Balance of Trade 59

COMPETITION 61

TRADE ASSOCIATIONS 61

CAPC61

CCCMHPIE 61

CPIA 61

RDPAC 62

TRADE FAIRS 63

Interphex China63

PharmChina 63

COMPANY INTELLIGENCE 64

Foreign Manufacturers64

Astellas Pharma64

AstraZeneca64

Boehringer Ingelheim 65

Bristol-Myers Squibb66

Daiichi Sankyo 66

Dainippon Sumitomo Pharma 67

Dragon Pharmaceuticals 67

Eisai68

Eli Lilly 68

GlaxoSmithKline 69

Johnson & Johnson69

Merck KGaA 70

Merck Sharp & Dohme70

Mitsubishi Tanabe Pharma 71

Novartis 71

Novo Nordisk 72

Pfizer 73

Roche 74

Sanofi 74

SciClone 75

Servier 76

Shionogi 76

Takeda 77

Local Manufacturers 78

Beijing Double-Crane Pharmaceutical79

China Pharmaceutical Group 80

Harbin Pharmaceutical Group 81

Joincare Pharmaceutical Group 82

North China Pharmaceutical 82

Shanghai Pharmaceuticals 83

Tianjin Tasly Pharmaceutical 84

The United Laboratories International 85

Zhejiang Hisun Pharmaceutical86

Zhejiang Medicine 87

OTC PHARMACEUTICALS 89

REGULATION 89

MARKET SIZE 89

COMPETITION 90

Trade Association90

CNMA90

Foreign Company Intelligence90

Sanofi90

Local Company Intelligence 90

China Sky One Medical90

GENERIC PHARMACEUTICALS 92

REGULATION 92

Prescribing Regulation92

MARKET SIZE 92

COMPETITION 92

Foreign Company Intelligence92

AstraZeneca 92

Sandoz 92

Watson93

Local Company Intelligence 93

China Pharma 93

Qilu Pharmaceutical 94

Shanghai Fosun Pharmaceutical 95

BIOLOGICS & BIOSIMILARS 96

REGULATION 96

MARKET SIZE 96

PRODUCT DEVELOPMENT 96

COMPETITION 97

Foreign Company Intelligence97

GlaxoSmithKline 97

Microbix 97

NeoStem97

Sanofi98

Local Company Intelligence 99

3SBIO99

Anhui Anke Biotech100

Beijing SL Pharmaceutical 101

China Biologic Products 102

Harbin Gloria Pharmaceuticals 103

Kun Run Biotechnology 103

Lanzhou Institute of Biological Products103

Livzon Pharmaceutical Group 104

Nuokang Bio-Pharmaceutical 105

Shenzhen Hepalink Pharmaceutical 106

Simcere Pharmaceutical Group 107

Sinovac Biotech 108

Walvax Biotechnology 110

WuXi PharmaTech 110

CONCLUSIONS: OPPORTUNITIES & CHALLENGES112

Strategic Espicom Analysis 112

MACROENVIRONMENT 112

EPIDEMIOLOGY 112

HEALTHCARE 113

REGULATORY AFFAIRS 113

PRICING & REIMBURSEMENT 114

DISTRIBUTION CHANNELS 114

MARKET 114

COMPETITION 115

OTC PHARMACEUTICALS 115

GENERIC PHARMACEUTICALS116

BIOLOGICS & BIOSIMILARS 116

Radar Analysis 118

SWOT Analysis 118

DIRECTORY 119

GOVERNMENT ORGANISATIONS 119

PHARMACEUTICAL DISTRIBUTORS119

Pharmaceutical Wholesalers 119

Pharmaceutical Retailers 119

PHARMACEUTICAL MANUFACTURERS119

Foreign Pharmaceutical Manufacturers119

Local Pharmaceutical Manufacturers 120

Foreign OTC Manufacturer 120

Local OTC Manufacturer 120

Foreign Generic Manufacturers 120

Local Generic Manufacturers120

Foreign Biologic Manufacturers 120

Local Biologic Manufacturers121

TRADE ORGANISATIONS121

List of Tables

Espicom Analysis of the Pharmaceutical Market, 2012 2Key Data Projections, 2012-2017 3Political Landscape, 2012 4Regional Ranking of Projected Economies, 2017 5Projected Economy, 2012-2017 5Regional Ranking of Projected Demographics, 2017 8Projected Demographics, 2012-2017 8Demographic Indicators, 2004-2010 9Leading Causes of Death, 2010 10Reported Infectious Diseases, 2001-2010 (Rate/100,000 Population) 11Regional Ranking of Projected Health Expenditure, 2017 15Projected Health Expenditure, 2012-201715Healthcare Expenditure by Type, 2000-2009 (CNY Billions) 16Hospitals, 2000-2008 18Hospitals by Region & Municipality, 2008 18Outpatient Institutions by Type, 2001-2008 19Health Centres & Clinics by Region & Municipality, 2008 19Inpatient Admissions, 2002-2008 (Millions) 20 Inpatient Admissions by Type & Institution, 2008 (10,000s) 20Outpatient Visits, 1999-2008 (Millions) 21Outpatient Visits by Type & Institution, 2008 (Millions) 21Regional Ranking of Projected Physicians, 2017 22Projected Physicians, 2012-2017 22Medical Personnel by Type, 2008 (000s) 23Physicians by Region & Municipality, 2008 (000s) 23Chindex Operating Results, 2006-2010 (US$ 000s) 35Chindex Revenue by Business Segment, 2006-2010 (US$000s) 36First China Pharmaceutical Group Operating Results, 2010-2011 (US$ 000s) 36Guangzhou Pharmaceutical Operating Results, 2007-2011 (CNY 000s) 37Hutchison China MediTech Operating Results, 2006-2010 (US$ 000s) 38Jointown Pharmaceutical Group Operating Results, 2007-2010 (CNY 000s) 39Nanjing Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 39Shanghai Pharmaceuticals Revenue by Business Segment, 2009-2010 (CNY 000s) 40Sinopharm Operating Results, 2006-2010 (CNY 000s) 41Sinopharm Revenue by Business Segment, 2006-2010 (CNY 000s) 41Regional Ranking of Projected Pharmaceutical Markets, 2017 43Projected Pharmaceutical Market at Retail Prices, 2012-2017 45Historical Pharmaceutical Market at Retail Prices, 1995-2011 45Pharmaceutical Sales at Retail Prices, 2000-2011 (CNY Billions)46Pharmaceutical Sales by Sector, 2009-2010 (CNY Billions) 47Pharmaceutical & Medical Device Output, 1998-2011 (CNY Billions) 50Pharmaceutical & Medical Device Output by Type, 2010 (CNY Billions) 51Pharmaceutical Exports by Category, 1995-2010 (US$000s) 52Pharmaceutical Exports by Country/Region, 2010 (US$000s) 54Pharmaceutical Imports by Category, 1995-2010 (US$000s) 55Imports of Raw Materials by Country/Region, 2010 (US$000s) 57Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 57Imports of Medicaments by Country/Region, 2010 (US$000s) 58Pharmaceutical Balance of Trade, 1995-2010 (US$000s) 59RDPAC Members, 2011 62AstraZeneca Revenue by Country, 2006-2010 (US$ 000s) 64Dainippon Sumitomo Pharma Revenue, 2010 (¥ 000s) 67Eisai Revenue by Country, 2009-2010 (¥ 000s)68Merck KGaA Revenue by Country & Type, 2010-2011 (€ 000s) 70Novo Nordisk Revenue by Country, 2006-2010 (DKK 000s) 72Sanofi Revenue by Country, 2010 (€ 000s) 75SciClone Revenue, 2006-2010 (US$ 000s) 76Top 25 Local Pharmaceutical Manufacturers by Revenue, 2010 (US$ 000s) 78Beijing Double-Crane Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 79China Pharmaceutical Group Operating Results, 2006-2010 (HK$ 000s) 80China Pharmaceutical Group Revenue by Geographical Area, 2006-2010 (HK$ 000s) 80China Pharmaceutical Group Revenue by Business Segment, 2006-2010 (HK$ 000s) 81Harbin Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 81Joincare Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 82North China Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 83Shanghai Pharmaceuticals Revenue by Business Segment & Drug Type, 2009-2010 (CNY 000s) 84Tianjin Tasly Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 84The United Laboratories International Operating Results, 2006-2010 (HK$ 000s) 85The United Laboratories International Revenue by Geographical Area, 2006-2010 (HK$ 000s) 85The United Laboratories International Revenue by Business Segment, 2006-2010 (HK$ 000s) 86Zhejiang Hisun Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 87Zhejiang Medicine Operating Results, 2006-2010 (CNY 000s)88OTC Pharmaceutical Sales, 2005-2009 (CNY Billions) 89China Sky One Medical Operating Results, 2006-2010 (US$ 000s) 91China Sky One Medical Revenue by Product Area, 2007-2010 (US$ 000s) 91China Pharma Operating Results, 2007-2010 (US$ 000s) 93China Pharma Revenue by Therapeutic Area, 2009-2010 (US$ 000s) 94Shanghai Fosun Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 95Shanghai Fosun Pharmaceutical Revenue by Business Segment, 2007-2010 (CNY 000s) 95NeoStem Operating Results, 2009-2010 (US$ 000s) 983SBIO Operating Results, 2006-2010 (CNY 000s) 993SBIO Foreign Revenue by Geographical Area, 2006-2010 (CNY 000s) 993SBIO Revenue by Product Type, 2006-2010 (CNY 000s) 100Anhui Anke Biotech Operating Results, 2006-2010 (CNY 000s) 101Beijing SL Pharmaceutical Operating Results, 2006-2010 (CNY 000s) 101China Biologic Products Operating Results, 2006-2010 (US$ 000s) 102China Biologic Products Revenue by Product Area, 2006-2010 (US$ 000s) 102Harbin Gloria Pharmaceuticals Operating Results, 2007-2010 (CNY 000s) 103Livzon Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 104Livzon Pharmaceutical Group Operating Income by Product Area, 2006-2010 (CNY 000s) 105Nuokang Bio-Pharmaceutical Operating Results, 2008-2010 (CNY 000s) 106Shenzhen Hepalink Pharmaceutical Operating Results, 2007-2010 (CNY 000s) 107Simcere Pharmaceutical Group Operating Results, 2006-2010 (CNY 000s) 108Sinovac Biotech Operating Results, 2006-2010 (US$ 000s) 109Sinovac Biotech Revenue by Product Area, 2006-2010 (US$ 000s) 109Walvax Biotechnology Operating Results, 2007-2010 (CNY 000s) 110WuXi PharmaTech Operating Results, 2006-2010 (US$ 000s) 111WuXi PharmaTech Revenue by Business Segment, 2006-2010 (US$ 000s)111WuXi PharmaTech Revenue by Geographical Area, 2006-2010 (US$ 000s)111Espicom Analysis of the Pharmaceutical Market, 2012 117SWOT Analysis of the Pharmaceutical Market, 2012 118

List of Charts

Regional Comparison of Top 5 Projected Pharmaceutical Markets at Retail Prices, 2017 44

Regional Comparison of Projected Pharmaceutical Market Share, 2017 44

Historical Pharmaceutical Market at Retail Prices, 1995-201146

Pharmaceutical Sales at Retail Prices, 2000-2011 (CNY Billions) 47

Pharmaceutical & Medical Device Output, 1998-2011 (CNY Billions) 50

Pharmaceutical Exports, 1995-2010 (US$ Billions) 53

Pharmaceutical Imports, 1995-2010 (US$ Billions) 55

Pharmaceutical Imports by Country/Region, 2010 (%) 56

Pharmaceutical Balance of Trade, 1995-2010 (US$ Billions)60

OTC Pharmaceutical Sales, 2005-2009 (CNY Billions) 89

Radar Graph of the Pharmaceutical Market, 2012 118